Juha Kukkonen1, Antti Joukainen2, Janne Lehtinen3, Kimmo T Mattila4, Esa K J Tuominen4, Tommi Kauko5, Ville Äärimaa4. 1. Department of Orthopaedics and Traumatology, Satakunta Central Hospital, Sairaalantie 3, 28500 Pori, Finland. E-mail address: jupeku@utu.fi. 2. Department of Orthopaedics and Traumatology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland. E-mail address: antti.joukainen@kuh.fi. 3. Department of Orthopaedics and Traumatology, Hatanpää Hospital, P.O. Box 437, 33101 Tampere, Finland. E-mail address: janne.lehtinen@tampere.fi. 4. Medical Imaging Centre of Southwest Finland (K.T.M. and E.K.J.T.) and Department of Orthopaedics and Traumatology (V.Ä.), Turku University Hospital, P.O. Box 28, 20701 Turku, Finland. E-mail address for K.T. Mattila: kimmo.mattila@tyks.fi. E-mail address for E.K.J. Tuominen: esa.tuominen@iki.fi. E-mail address for V. Äärimaa: ville.aarimaa@tyks.fi. 5. Department of Biostatistics, University of Turku, Lemminkäisenkatu 1, 20014 Turun yliopisto, Finland. E-mail address: tokauk@utu.fi.
Abstract
BACKGROUND: The optimal treatment for symptomatic, nontraumatic rotator cuff tear is unknown. The purpose of this trial was to compare the effectiveness of physiotherapy, acromioplasty, and rotator cuff repair for this condition. We hypothesized that rotator cuff repair yields superior results compared with other treatment modalities. METHODS:One hundred and eighty shoulders with symptomatic, nontraumatic, supraspinatus tears were randomized into one of three cumulatively designed intervention groups: the physiotherapy-only group (denoted as Group 1), the acromioplasty and physiotherapy group (denoted as Group 2), and the rotator cuff repair, acromioplasty, and physiotherapy group (denoted as Group 3). The Constant score was the primary outcome measure. Secondary outcome measures were visual analog scale for pain, patient satisfaction, rotator cuff integrity in a control imaging investigation, and cost of treatment. RESULTS:One hundred and sixty-seven shoulders (160 patients) were available for analysis at two years. There were no significant differences (p = 0.38) in the mean change of Constant score: 18.4 points (95% confidence interval, 14.2 to 22.6 points) in Group 1, 20.5 points (95% confidence interval, 16.4 to 24.6 points) in Group 2, and 22.6 points (95% confidence interval, 18.4 to 26.8 points) in Group 3. There were no significant differences in visual analog scale for pain scores (p = 0.45) and patient satisfaction (p = 0.28) between the groups. At two years, the mean sagittal size of the tendon tear was significantly smaller (p < 0.01) in Group 3 (4.2 mm) compared with Groups 1 and 2 (11.0 mm). Rotator cuff repair and acromioplasty were significantly more expensive than physiotherapy only (p < 0.01). CONCLUSIONS: There was no significant difference in clinical outcome between the three interventions at the two-year follow-up. The potential progression of the rotator cuff tear, especially in the non-repaired treatment groups, warrants further follow-up. On the basis of our findings, conservative treatment is a reasonable option for the primary initial treatment for isolated, symptomatic, nontraumatic, supraspinatus tears in older patients. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.
RCT Entities:
BACKGROUND: The optimal treatment for symptomatic, nontraumatic rotator cuff tear is unknown. The purpose of this trial was to compare the effectiveness of physiotherapy, acromioplasty, and rotator cuff repair for this condition. We hypothesized that rotator cuff repair yields superior results compared with other treatment modalities. METHODS: One hundred and eighty shoulders with symptomatic, nontraumatic, supraspinatus tears were randomized into one of three cumulatively designed intervention groups: the physiotherapy-only group (denoted as Group 1), the acromioplasty and physiotherapy group (denoted as Group 2), and the rotator cuff repair, acromioplasty, and physiotherapy group (denoted as Group 3). The Constant score was the primary outcome measure. Secondary outcome measures were visual analog scale for pain, patient satisfaction, rotator cuff integrity in a control imaging investigation, and cost of treatment. RESULTS: One hundred and sixty-seven shoulders (160 patients) were available for analysis at two years. There were no significant differences (p = 0.38) in the mean change of Constant score: 18.4 points (95% confidence interval, 14.2 to 22.6 points) in Group 1, 20.5 points (95% confidence interval, 16.4 to 24.6 points) in Group 2, and 22.6 points (95% confidence interval, 18.4 to 26.8 points) in Group 3. There were no significant differences in visual analog scale for pain scores (p = 0.45) and patient satisfaction (p = 0.28) between the groups. At two years, the mean sagittal size of the tendon tear was significantly smaller (p < 0.01) in Group 3 (4.2 mm) compared with Groups 1 and 2 (11.0 mm). Rotator cuff repair and acromioplasty were significantly more expensive than physiotherapy only (p < 0.01). CONCLUSIONS: There was no significant difference in clinical outcome between the three interventions at the two-year follow-up. The potential progression of the rotator cuff tear, especially in the non-repaired treatment groups, warrants further follow-up. On the basis of our findings, conservative treatment is a reasonable option for the primary initial treatment for isolated, symptomatic, nontraumatic, supraspinatus tears in older patients. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.
Authors: James Rickert; Tom Boniface; Dwight W Burney; Tom Grogan; Paul E Levin; Mark Piasio; Rob Rutherford; Alexandra E Page Journal: Clin Orthop Relat Res Date: 2017-06-27 Impact factor: 4.176
Authors: A A Narvani; M A Imam; A Godenèche; E Calvo; S Corbett; A L Wallace; E Itoi Journal: Ann R Coll Surg Engl Date: 2020-01-03 Impact factor: 1.891
Authors: Nitin B Jain; Gregory D Ayers; Run Fan; John E Kuhn; Jon J P Warner; Keith M Baumgarten; Elizabeth Matzkin; Laurence D Higgins Journal: Am J Sports Med Date: 2019-09-13 Impact factor: 6.202